Prevention of pruritus with ethyl-chloride in skin prick test: a double-blind placebo-controlled prospective study

被引:1
|
作者
Gal-Oz, Amir [1 ,2 ,3 ]
Kivity, Shmuel [3 ]
Shacham, Yacov [3 ]
Fiszer, Elisheva [3 ]
Rogowsky, Ori [4 ]
Chernin, Gil [1 ,2 ]
机构
[1] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Dept Nephrol, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Med, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Dept Allergy, IL-64239 Tel Aviv, Israel
[4] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Internal Med Dept G Tel Aviv, IL-64239 Tel Aviv, Israel
来源
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY | 2015年 / 11卷
关键词
Ethyl-chloride spray; Histamine skin-prick test; PAIN REDUCTION; HISTAMINE; FLARE; ITCH; NEUROPHYSIOLOGY; RECEPTORS; RESPONSES; ALLERGY; WHEAL;
D O I
10.1186/s13223-015-0091-z
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Ethyl-chloride (EC) spray was recently shown to be an effective antipruritic agent, when given 15 min after histamine skin-prick test (SPT), without changing the wheal and flare reaction. We aimed to investigate the antipruritic effect of EC on SPT, when given prior to SPT. Methods: A double-blind placebo-controlled prospective study. Overall, 44 volunteers underwent histamine SPT on both arms to trigger local pruritus. Prior to test, they were randomly treated with EC spray on one arm and saline spray (placebo) on the other. Subjects as well as researchers were blinded to the type of applied sprays. The wheal and flare reaction was measured after the SPT and subjects reported the intensity of pruritus following EC/placebo using a validated pruritus questionnaire (indexes 1-3) and a visual analog scale (VAS). Results: Significant improvement in pruritus was reported following treatment with EC compared with placebo for all four studied parameters. Index 1 in EC 3.7 +/- 2.3 versus 5 +/- 3.5 (p = 0.007) in placebo, index 2 in EC 2.6 +/- 2.1 versus 3.8 +/- 2.8 (p = 0.002) in placebo, index 3 of EC 6.3 +/- 3.8 versus 8.8 +/- 5.8 (p = 0.03) and VAS in EC 3.7 +/- 1.9 versus 4.4 +/- 2.3 (p = 0.003). There were no significant differences between EC and placebo in terms of the wheal and flare indurations area. Conclusions: Ethyl-chloride has an effective antipruritic agent, when given before histamine SPT. Its use did not change the wheal and flare reaction, making it ideal for prevention of pruritus, secondary to allergy skin test, without masking the results.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] OXIRACETAM IN DEMENTIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    BOTTINI, G
    VALLAR, G
    CAPPA, S
    MONZA, GC
    SCARPINI, E
    BARON, P
    CHELDI, A
    SCARLATO, G
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (03): : 237 - 241
  • [32] Dexamethasone for the prevention of postextubation airway obstruction: A prospective, randomized, double-blind, placebo-controlled trial
    Anene, O
    Meert, KL
    Uy, H
    Simpson, P
    Sarnaik, AP
    CRITICAL CARE MEDICINE, 1996, 24 (10) : 1666 - 1669
  • [33] Safety of strontium ranelate in prevention of postmenopausal bone loss - a double-blind, prospective, placebo-controlled study.
    Reginster, JY
    Roux, C
    Jupsin, I
    Tupinon-Mathieu, I
    Tsouderos, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S412 - S412
  • [34] Prevention of ventilator-associated pneumonia by oral decontamination - A prospective, randomized, double-blind, placebo-controlled study
    Bergmans, DCJJ
    Bonten, MJM
    Gaillard, CA
    Paling, JC
    van der Geest, S
    van Tiel, FH
    Beysens, AJ
    de Leeuw, PW
    Stobberingh, EE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) : 382 - 388
  • [35] NALOXONE AMELIORATES THE PRURITUS OF CHOLESTASIS - RESULTS OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
    BERGASA, NV
    ALLING, DW
    TALBOT, TL
    SWAIN, MG
    FRIED, MW
    FONG, TL
    YURDAYDIN, C
    SCHMITT, JM
    WALKER, EC
    TURNER, ML
    JONES, EA
    HEPATOLOGY, 1992, 16 (04) : A152 - A152
  • [36] Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia
    Cooper, SJ
    Butler, A
    Tweed, J
    Welch, C
    Raniwalla, J
    PSYCHOPHARMACOLOGY, 2000, 150 (03) : 237 - 243
  • [37] Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study
    Jablonowska, B
    Selbing, A
    Palfi, M
    Ernerudh, J
    Kjellberg, S
    Lindton, B
    HUMAN REPRODUCTION, 1999, 14 (03) : 838 - 841
  • [38] Efficacy of dexpanthenol in skin protection against irritation:: a double-blind, placebo-controlled study
    Biro, K
    Thaçi, D
    Ochsendorf, FR
    Kaufmann, R
    Boehncke, WH
    CONTACT DERMATITIS, 2003, 49 (02) : 80 - 84
  • [39] Effect of a novel supplemented drink on skin aging: A double-blind, placebo-controlled study
    Wainwright, L. J.
    Barrett, K. E.
    Casey, J.
    Jenkins, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S48 - S48
  • [40] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
    MURPHY, JJ
    HEPTINSTALL, S
    MITCHELL, JRA
    LANCET, 1988, 2 (8604): : 189 - 192